These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37886318)

  • 1. Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9824504. PubMed ID: 37886318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway.
    Wen S; Hu M; Xiong Y
    J Healthc Eng; 2021; 2021():6091585. PubMed ID: 34804455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway.
    He J; Fu H; Li C; Deng Z; Chang H
    Phytomedicine; 2022 Jul; 102():154159. PubMed ID: 35580441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells
    Li W; Du Q; Li X; Zheng X; Lv F; Xi X; Huang G; Yang J; Liu S
    Front Pharmacol; 2020; 11():114. PubMed ID: 32158391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
    Markers D
    Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864562. PubMed ID: 37476776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Valproic Acid Inhibits Peripheral T Cell Lymphoma Cells Behaviors via Restraining PI3K/AKT Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9865432. PubMed ID: 37593027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9765985. PubMed ID: 37799431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9769574. PubMed ID: 38125075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Cardiac Contractility Modulation Attenuates Chronic Heart Failure in a Rabbit Model via the PI3K/AKT Pathway.
    International BR
    Biomed Res Int; 2024; 2024():9760278. PubMed ID: 38549959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted:
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9817815. PubMed ID: 37565156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway.
    Shan H; Zhang X; Mi Y; Jia J; Wang B; Yang Q
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Prescription of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9878935. PubMed ID: 37564797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
    Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
    Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Markers D
    Dis Markers; 2023; 2023():9791279. PubMed ID: 37476639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9819824. PubMed ID: 37388518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9768306. PubMed ID: 37387989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.